Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients

[1]  F. Willermain,et al.  Clinical Outcome of Hypertensive Uveitis , 2015, Journal of ophthalmology.

[2]  N. Koizumi,et al.  Clinical features and management of cytomegalovirus corneal endotheliitis: analysis of 106 cases from the Japan corneal endotheliitis study , 2014, British Journal of Ophthalmology.

[3]  H. Hengel,et al.  Human Cytomegalovirus and Autoimmune Disease , 2014, BioMed research international.

[4]  D. Miyazaki,et al.  Relationship between the number of cytomegalovirus in anterior chamber and severity of anterior segment inflammation , 2013, Japanese Journal of Ophthalmology.

[5]  S. W. Park,et al.  Association of Cytomegalovirus with Idiopathic Chronic Anterior Uveitis with Ocular Hypertension in Korean Patients , 2013, Ocular immunology and inflammation.

[6]  V. Appay,et al.  CMV and Immunosenescence: from basics to clinics , 2012, Immunity & Ageing.

[7]  Y. Tsai,et al.  Immune ring formation associated with cytomegalovirus endotheliitis. , 2012, American journal of ophthalmology.

[8]  T. Higashide,et al.  Clinical significance of owl eye morphologic features by in vivo laser confocal microscopy in patients with cytomegalovirus corneal endotheliitis. , 2012, American journal of ophthalmology.

[9]  Soon-Phaik Chee,et al.  Viral anterior uveitis , 2011, Current opinion in ophthalmology.

[10]  H. Yu,et al.  Cytomegalovirus Endotheliitis after Fluocinolone Acetonide (Retisert) Implant in a Patient with Behçet Uveitis , 2011, Ocular immunology and inflammation.

[11]  N. Rao.  Journal of Ophthalmic Inflammation and Infection: why a new journal on ocular inflammation? , 2010, Journal of ophthalmic inflammation and infection.

[12]  S. Chee,et al.  Emerging Forms of Viral Uveitis in the Developing World , 2010, International ophthalmology clinics.

[13]  S. Chee,et al.  Cytomegalovirus endotheliitis following fluocinolone acetonide (Retisert) implant , 2010, Eye.

[14]  A. Çağatay,et al.  CMV retinitis after intravitreal triamcinolone acetonide injection in a patient with Behçet’s uveitis , 2010, International Ophthalmology.

[15]  S. Duman,et al.  Incidence and prognosis of ocular hypertension secondary to viral uveitis , 2010, International Ophthalmology.

[16]  S. Chee,et al.  Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients. , 2008, American journal of ophthalmology.

[17]  C. Söderberg-Nauclér.  HCMV microinfections in inflammatory diseases and cancer. , 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[18]  A. van der Lelij,et al.  Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. , 2007, Ophthalmology.

[19]  S. Chee,et al.  Corneal endotheliitis associated with evidence of cytomegalovirus infection. , 2007, Ophthalmology.

[20]  Rishi P. Singh,et al.  Cytomegalovirus retinitis after fluocinolone acetonide (Retisert) implant. , 2007, American journal of ophthalmology.

[21]  P. Lehner,et al.  Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Alexander,et al.  Human Cytomegalovirus Induces Monocyte Differentiation and Migration as a Strategy for Dissemination and Persistence , 2004, Journal of Virology.

[23]  M. Jeffrey,et al.  Granulomatous anterior uveitis associated with 0.2% topical brimonidine , 2003, Eye.

[24]  B. Johansson,et al.  Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study , 2002, Experimental Gerontology.

[25]  H. Volk,et al.  CCAAT/Enhancer-binding Proteins α and β Negatively Influence the Capacity of Tumor Necrosis Factor α to Up-regulate the Human Cytomegalovirus IE1/2 Enhancer/Promoter by Nuclear Factor κB during Monocyte Differentiation* , 2001, The Journal of Biological Chemistry.

[26]  H. Volk,et al.  CCAAT/enhancer-binding proteins alpha and beta negatively influence the capacity of tumor necrosis factor alpha to up-regulate the human cytomegalovirus IE1/2 enhancer/promoter by nuclear factor kappaB during monocyte differentiation. , 2001, Journal of Biological Chemistry.

[27]  R. Goyal,et al.  Brimonidine tartarate 0.2% (Alphagan) associated granulomatous anterior uveitis , 2000, Eye.

[28]  J. Bullock,et al.  Cystoid macular edema and anterior uveitis associated with latanoprost use. Experience and incidence in a retrospective review of 94 patients. , 1998, Ophthalmology.

[29]  H. Volk,et al.  Stimulation of the Human Cytomegalovirus IE Enhancer/Promoter in HL-60 Cells by TNFα Is Mediated via Induction of NF-κB , 1995 .

[30]  H. Volk,et al.  Stimulation of the human cytomegalovirus IE enhancer/promoter in HL-60 cells by TNFalpha is mediated via induction of NF-kappaB. , 1995, Virology.

[31]  J. Sissons,et al.  Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. , 1991, The Journal of general virology.